For investor inquiries, please contact Ms. Melodee Newbold at 909 307 9300
or email Investor Relations at InvestorRelations@genelux.com

For media inquiries please call
909 307 9300 or email Investor Relations at InvestorRelations@genelux.com

Genelux Corporation does not recruit or select patients for clinical trials. Information about selection can be obtained from participating clinical partners or on the web at www.clinicaltrials.gov

For general information, please contact:

Genelux is headquartered in San Diego, California with an Investor Relations office in Redlands, California.